T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
TripAdvisor
TRIP
$1.26B
| $184M | 0.04% |
2,216,307
-260,192
| -11% | -$20.5M |
|
452
Franklin Electric
FELE
$4.75B
| $184M | 0.04% |
4,820,615
+700
| +0% | +$25.1K |
|
453
Goldman Sachs
GS
$302B
| $184M | 0.04% |
976,848
-84,815
| -8% | -$15.8M |
|
454
Expeditors International
EXPD
$24B
| $181M | 0.04% |
3,766,033
-22,177
| -0.6% | -$1.02M |
|
455
Camden Property Trust
CPT
$10.9B
| $181M | 0.04% |
2,311,052
+7,117
| +0.3% | +$546K |
|
456
Mine Safety
MSA
$7.41B
| $180M | 0.04% |
3,605,539
-101,700
| -3% | -$4.91M |
|
|
FRGI
457
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $179M | 0.04% |
2,929,800
+163,384
| +6% | +$10.2M |
|
458
CenterPoint Energy
CNP
$26.7B
| $178M | 0.04% |
8,730,859
+6,535,591
| +298% | +$143M |
|
459
Capitol Federal Financial
CFFN
$1.1B
| $176M | 0.04% |
14,059,253
+86,692
| +0.6% | +$1.09M |
|
460
Marathon Petroleum
MPC
$97.8B
| $175M | 0.04% |
3,421,686
+1,241,368
| +57% | +$59.6M |
|
|
CSC
461
DELISTED
Computer Sciences
CSC
| $175M | 0.04% |
6,354,272
-2,746,522
| -30% | -$75.8M |
|
462
Insmed
INSM
$28.9B
| $174M | 0.04% |
8,371,147
+7,940,960
| +1,846% | +$140M |
|
463
Regions Financial
RF
$26.9B
| $174M | 0.04% |
18,414,865
-25,140
| -0.1% | -$238K |
|
|
PF
464
DELISTED
Pinnacle Foods, Inc.
PF
| $173M | 0.04% |
4,246,350
+226,655
| +6% | +$8.4M |
|
465
Clearwater Paper
CLW
$356M
| $173M | 0.04% |
2,653,706
-21,745
| -0.8% | -$1.45M |
|
|
CORE
466
DELISTED
Core Mark Holding Co., Inc.
CORE
| $172M | 0.04% |
5,357,200
+29,000
| +0.5% | +$950K |
|
467
NewMarket
NEU
$8.59B
| $172M | 0.04% |
360,424
+303,824
| +537% | +$137M |
|
468
EastGroup Properties
EGP
$10.9B
| $171M | 0.04% |
2,849,640
+10,110
| +0.4% | +$635K |
|
469
Colgate-Palmolive
CL
$73.6B
| $171M | 0.04% |
2,462,236
-31,098
| -1% | -$2.15M |
|
470
TE Connectivity
TEL
$62B
| $170M | 0.04% |
2,368,110
+13,996
| +0.6% | +$962K |
|
471
M&T Bank
MTB
$36.6B
| $170M | 0.04% |
1,335,208
+130,424
| +11% | +$15.8M |
|
|
CLVS
472
DELISTED
Clovis Oncology, Inc.
CLVS
| $169M | 0.03% |
2,275,482
+62,078
| +3% | +$4.38M |
|
473
CME Group
CME
$94.3B
| $169M | 0.03% |
1,780,492
+97,657
| +6% | +$9.05M |
|
474
Fortinet
FTNT
$118B
| $168M | 0.03% |
24,078,175
+11,746,250
| +95% | +$76.7M |
|
|
EIGI
475
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $166M | 0.03% |
8,694,079
+2,036,021
| +31% | +$37.2M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.